Leading integrated radiotherapy systems maker Varian Medical Systems (VAR) will feature its new X-ray tubes and PaxScan flat panel image detectors at the China International Medical Equipment Fair (“CMEF”) meet, slated to be held in Shenzhen from April 16 to April 19, 2011. CMEF is the largest exhibition of medical equipment in the Asia-Pacific region.
Varian plans to showcase, at the CMEF, a wide range of advanced X-ray tubes designed for radiographic/fluoroscopic imaging, computed axial tomography (“CT”), special procedures and mammography applications. The California-based company will also feature new cancer treatment technologies.
Moreover, Varian will highlight its PaxScan dynamic X-ray image detectors including the new PaxScan 3024M flat panel detector for full field digital mammography. Its compact structure with inherent quick image acquisition capacity permits medical practitioners to take pictures near the chest with spontaneous outcome.
In addition to the PaxScan 3024M, other flat panel detectors such as the PaxScan radiographic X-ray image detectors (PaxScan 4343R and PaxScan 4336R) will also be showcased at the CMEF. Varian believes that the new products will offer good value by combining enhanced image quality, higher patient throughput and greater cost-efficiency.
Varian is the world’s leading manufacturer of integrated radiotherapy systems for treating cancer and a premier supplier of X-ray tubes for diagnostic imaging applications. In the radiation oncology market, the company competes head-to-head with Accuray Incorporated (ARAY).
Varian’s X-ray products segment is a distinct business unit, set apart from its oncology products business. The company offers over 400 categories of medical and industrial X-ray tubes, besides its PaxScan series of silicon flat panel detectors for digital radiography or imaging without using films.
Varian is poised to increase its market share in the radiation oncology market. The company is currently enjoying a healthy demand for its coveted RapidArc radiotherapy technology, which is meaningfully contributing to its oncology net order growth.
Strong order activity at Varian’s oncology systems segment as well as current momentum in the X-ray products business is expected to set the stage for better performance in 2011. Currently, we have a Neutral recommendation on the stock.
ACCURAY INC (ARAY): Free Stock Analysis Report
VARIAN MEDICAL (VAR): Free Stock Analysis Report
Zacks Investment Research
